BioInformant

Your Global Leader in Stem Cell Market Research

The Cord Blood Banking Price War is Getting Fierce – and Consumers Are Benefiting

By Leave a Comment

The cost of cord blood banking is extremely affordable due to heated competition. Families now have more options to choose from than ever before.

Cord blood banking is becoming an increasingly common practice. More and more, new parents are becoming aware of the benefits of storing their newborn’s umbilical cord blood – a rich source of stem cells that can be used for life-saving medical treatment in the future. However, the biggest barrier for many families, has been the price.

Cord blood banks have been in a stem cell banking price war, and fortunately, it has made storage more affordable. [Read more…]

Stem Cell Treatment For Hair Loss in 2026

By 9 Comments

The latest development in stem cell research – stem cell treatment for hair loss – shows great promise for stimulating new hair growth. It addresses the problem of thinning hair for both men and women.

When hair growth slows with age, many people feel despondent, depressed, less confident, or unhappy. The prospect of a continuing downhill slide makes the situation  worse, which is why stem cell transplant for hair loss has become a large business in the last several decades. [Read more…]

Free Cord Blood Programs for Families in Need

By Leave a Comment

In 2005, Congress passed the Stem Cell Therapeutic and Research Act, initiating the federally supported National Cord Blood Inventory (NCBI) program to increase the number of publicly available cord blood units for transplant. The law initially aimed to build an inventory of roughly 150,000 high-quality, diverse cord blood units to improve the likelihood of finding matches for patients in need. Today, the NCBI continues to contract with public cord blood banks across the United States, collecting and maintaining tens of thousands of units and making them searchable through the national registry for patients and physicians. [Read more…]

CHU Toulouse and Cell-Easy Launch A-MUSE, a Phase 1/2 Clinical Trial Evaluating the CellReady® Allogeneic MSC Platform in Systemic Sclerosis

By Leave a Comment

Toulouse, January 22, 2026 — Cell-Easy, a CDMO specialized in the development and GMP manufacturing of Advanced Therapy Medicinal Products (ATMPs), announces a new clinical milestone achieved in close collaboration with Toulouse University Hospital (CHU Toulouse). The European Medicines Agency (EMA) has granted Clinical Trial Authorization (CTA) for AMUSE, a Phase 1/2 clinical trial evaluating the safety and efficacy of an allogeneic mesenchymal stromal cell (MSC) therapy in patients with systemic sclerosis presenting perioral fibrosis and functional impairment. [Read more…]

Embryonic Stem Cells – Definition, Uses, and Limitations

By 1 Comment

Embryonic stem cells are cells that can give rise to all of the tissues types that form a human being. These stem cells are being used in drug development, toxicology testing, and disease reversal, as well as to grow healthy new tissue to heal injuries.

While they are powerful cells, embryonic stem cells are controversial to produce, because they are created from human embryos. For this reason, they have limited use and receive restricted funding. Learn more about these cells below. [Read more…]

Shopping cart0
There are no products in the cart!
Continue shopping
0